These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 33153765

  • 1. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells.
    He ZX, Huo JL, Gong YP, An Q, Zhang X, Qiao H, Yang FF, Zhang XH, Jiao LM, Liu HM, Ma LY, Zhao W.
    Eur J Med Chem; 2021 Jan 15; 210():112970. PubMed ID: 33153765
    [Abstract] [Full Text] [Related]

  • 2. Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent.
    He Z, Qiao H, Yang F, Zhou W, Gong Y, Zhang X, Wang H, Zhao B, Ma L, Liu HM, Zhao W.
    Eur J Med Chem; 2019 Dec 15; 184():111764. PubMed ID: 31614257
    [Abstract] [Full Text] [Related]

  • 3. Selective Cytotoxic Effects of 5-Trifluoromethoxy-1H-indole-2,3-dione 3-Thiosemicarbazone Derivatives on Lymphoid-originated Cells.
    Danışman-Kalındemirtaş F, Erdem-Kuruca S, Akgün-Dar K, Karakaş Z, Soylu Ö, Karali N.
    Anticancer Agents Med Chem; 2022 Dec 15; 22(2):349-355. PubMed ID: 33653255
    [Abstract] [Full Text] [Related]

  • 4. Design and Synthesis of Novel Cytotoxic Indole-Thiosemicarbazone Derivatives: Biological Evaluation and Docking Study.
    Bakherad Z, Safavi M, Fassihi A, Sadeghi-Aliabadi H, Bakherad M, Rastegar H, Saeedi M, Ghasemi JB, Saghaie L, Mahdavi M.
    Chem Biodivers; 2019 Apr 15; 16(4):e1800470. PubMed ID: 30845369
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D, Romagnoli R, Rondanin R, Cacciari B, Hamel E, Balzarini J, Liekens S, Schols D, Estévez-Sarmiento F, Quintana J, Estévez F.
    J Enzyme Inhib Med Chem; 2018 Dec 15; 33(1):1225-1238. PubMed ID: 30141353
    [Abstract] [Full Text] [Related]

  • 6. Thiosemicarbazone-based lead optimization to discover high-efficiency and low-toxicity anti-gastric cancer agents.
    Zhang XH, Bo-Wang, Tao YY, Ma Q, Wang HJ, He ZX, Wu HP, Li YH, Zhao B, Ma LY, Liu HM.
    Eur J Med Chem; 2020 Aug 01; 199():112349. PubMed ID: 32438199
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F, Li W, Shuai W, Yang L, Bi Y, Ma C, Yao H, Xu S, Zhu Z, Xu J.
    Eur J Med Chem; 2019 Jul 01; 173():1-14. PubMed ID: 30981112
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L.
    Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
    Zhang M, Liang YR, Li H, Liu MM, Wang Y.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6623-6634. PubMed ID: 29126741
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
    Li Z, Luo M, Cai B, Haroon-Ur-Rashid, Huang M, Jiang J, Wang L, Wu L.
    Eur J Med Chem; 2018 Sep 05; 157():665-682. PubMed ID: 30125725
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.
    Youssif BGM, Abdelrahman MH, Abdelazeem AH, Abdelgawad MA, Ibrahim HM, Salem OIA, Mohamed MFA, Treambleau L, Bukhari SNA.
    Eur J Med Chem; 2018 Feb 25; 146():260-273. PubMed ID: 29407956
    [Abstract] [Full Text] [Related]

  • 12. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay.
    de Oliveira JF, Lima TS, Vendramini-Costa DB, de Lacerda Pedrosa SCB, Lafayette EA, da Silva RMF, de Almeida SMV, de Moura RO, Ruiz ALTG, de Carvalho JE, de Lima MDCA.
    Eur J Med Chem; 2017 Aug 18; 136():305-314. PubMed ID: 28505535
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
    Cheng C, Yun F, He J, Ullah S, Yuan Q.
    Eur J Med Chem; 2019 Jul 01; 173():185-202. PubMed ID: 31003060
    [Abstract] [Full Text] [Related]

  • 14. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
    Elsayed HE, Ebrahim HY, Haggag EG, Kamal AM, El Sayed KA.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6297-6312. PubMed ID: 29066046
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities.
    de Oliveira JF, da Silva AL, Vendramini-Costa DB, da Cruz Amorim CA, Campos JF, Ribeiro AG, Olímpio de Moura R, Neves JL, Ruiz AL, Ernesto de Carvalho J, Alves de Lima Mdo C.
    Eur J Med Chem; 2015 Nov 02; 104():148-56. PubMed ID: 26454648
    [Abstract] [Full Text] [Related]

  • 16. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
    Shao M, Yao M, Liu X, Gao C, Liu W, Guo J, Zong J, Sun X, Liu Z.
    Inorg Chem; 2021 Nov 15; 60(22):17063-17073. PubMed ID: 34709784
    [Abstract] [Full Text] [Related]

  • 17. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
    Wei XW, Yuan JM, Huang WY, Chen NY, Li XJ, Pan CX, Mo DL, Su GF.
    Eur J Med Chem; 2020 Jan 15; 186():111851. PubMed ID: 31761381
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells.
    Altintop MD, Sever B, Özdemir A, Kuş G, Oztopcu-Vatan P, Kabadere S, Kaplancikli ZA.
    J Enzyme Inhib Med Chem; 2016 Jan 15; 31(3):410-6. PubMed ID: 25826149
    [Abstract] [Full Text] [Related]

  • 19. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
    Lu Y, Wang L, Wang X, Xi T, Liao J, Wang Z, Jiang F.
    Eur J Med Chem; 2017 Jul 28; 135():125-141. PubMed ID: 28441581
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
    Shen QK, Deng H, Wang SB, Tian YS, Quan ZS.
    Eur J Med Chem; 2019 Jul 01; 173():15-31. PubMed ID: 30981113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.